So thanks. Thanks, Tim. And thanks for the invitation. It's a pleasure to speak with this audience. So in terms of I think I'm speaking to a US audience, most of them are probably aware of the of the two grills which to do similar things with DMA one is the American Innovation and Choice Online Act, S. 2992. And the other is the Open Up Markets Act, S.2710. And I think I would agree with Gerald here that we're not at loggerheads here, when it comes to some of these rules. You know, both these bills passed the with overwhelming bipartisan support, and the Senate Judiciary Committee. And I know the house versions as well of these bills, there was a letter of support by the DOJ or the belts, and we know the axelent office is also supportive. So I think there is momentum here in the US as well, to have similar rules to the DMA. And that's, those are the two things they're the next I would like to say there are similarities and how these, the DMA and the American Innovation Choice Online Act defined who's covered. But we have got platforms here as well. And it's based on similar criteria, focusing on companies who operate in the US based on the number of users in the US, which are online services, which reflects that, you know, these are companies which have an established base, but network effects, which is service, which is self reinforcing. Then the second bit is that we have a similar threshold, you know, a net sales or market capitalization threshold, which often reflects the fact that these companies operate across ecosystems. You know, the Google's the Facebook's, the Amazons, it captures the fact that they can leverage across different markets. And then finally, a market power type test in the US legislation is this criteria of critical trading partner for online platform to be covered platform, it also needs to be critical trading partner, I think this reflects the fact that in many cases, the largest the giant, the giant online platforms, effectively control the marketplaces or the appraisal sectors with conditions for these marketplaces. So it's a combination of all these three things, which are captured, I think, in both the DNA and the US version of these bills, which reflect these very complex sorts of the market problem. And you know, and then cover these different companies. I guess my job is only to go into detail of the of the American bills, but I'm happy to do that later offline and dusted. I'll just say a few words about the implementation of these bills. And so I think the commission has a lot of resources and I was 30 Commission's on take the lead here with the NRAS. In the US, it's going to be the FTC, the DOJ supported by state agencies, we definitely will need more, a lot more resources, to better resources equip these agencies to implement [inaudible], if it becomes it becomes law. And I think the DMA already has a lot of detail in it about what's covered what's not covered in some cases. And we're still in the bill in the US foresees that the FTC, FTC and DOJ will jointly come up with detailed guidelines in the year following the passage of the elephant becomes law. And during that chair, you know, the covered platforms and the DOJ can have a dialogue to come up with similar with withdrawals that are appropriate, more detailed rules, which are appropriate. So you know, we have a similar waiting period. Yeah, before anything takes effect. That's fine. Just one final point, if I might add some differences in the details of what the DMA does and what the American Innovation Choice Online Act does, for example, in a messaging service is not explicitly covered here. In the act in the US, a pre installation is not done. It's just the ability is the ability to give users to easily change default, to understand the DMA actually says that if you can't pre install some services, that's not the case here with the US still. And finally, I guess there are some sort of business law restrictions and the the DMA when it comes to data use, right you have this concept of data silos, etc. Which is again, not there in in the US, Bill. So I think they also have differences in approach. And another interesting challenge will be coordination on some of these remedies when they're implemented. Thank you.